dihexa pnb-0408 mechanism of action (also known as PNB-0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the blood–brain barrier and has shown synaptogenic effects in preclinical models. The often-quoted HDAC6 inhibitor-loaded brain-targeted nanocarrier-mediated neuroprotection
HDAC6 inhibitor loaded brain targeted nanocarrier mediated neuroprotection in methamphetamine driven Parkinson's disease ScienceDirect Cognitive peptides in research: Semax, Selank, Dihexa and the new generation of peptide nootropics Lab Peptides France Recent advances in the development of selective hMAO B inhibitors for neurodegenerative diseases: An update from 2020 to present ScienceDirect Dihexa UK: Evidence Based Peptide Research Guide
Pay in 4 interest-free payments of $7.36 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8



